Patent details

EP1313769 Title: ANTIBODIES TO HUMAN IL-1 BETA

Basic Information

Publication number:
EP1313769
PCT Application Number:
PCT/EP/2001/009588
Type:
European Patent Granted for LU
Legal Status:
Expired
Application number:
EP019761188
PCT Publication Number:
WO/2002/016436
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
ANTIBODIES TO HUMAN IL-1 BETA
French Title of Invention:
ANTICORPS DE LA IL-1 BETA HUMAINE
German Title of Invention:
ANTIKÖRPER GEGEN IL-1 BETA
SPC Number:
91624

Dates

Filing date:
20/08/2001
Grant date:
21/05/2008
EP Publication Date:
21/05/2008
PCT Publication Date:
28/02/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
28/05/2003
EP B1 Publication Date:
21/05/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
20/08/2021
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
20/08/2001
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
GRAM Hermann
Address:
Germany (DE)

2

Name:
DI PADOVA Franco, E.
Address:
Switzerland (CH)

Priority

Priority Number:
0020685
Priority Date:
22/08/2000
Priority Country:
United Kingdom (GB)

Classification

Main IPC Class:
C07K 16/24;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
10/08/2020
Last Annual Fee Paid Number:
20
Last Annual Fee Paid Amount:
300 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages